Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference NEW BRUNSWICK, N.J., April 7, 2022 Johnson & Johnson (NYSE: JNJ) will participate in the BofA Securities 2022 Healthcare Conference at the Encore...

Key Takeaway: NEW BRUNSWICK, N.J. , April 7, 2022 Johnson & Johnson (NYSE: JNJ ) will participate in the BofA Securities 2022 Healthcare Conference at the Encore Hotel in Las Vegas, Nevada on Wednesday, May 11 th . Ashley McEvoy, Executive Vice President, Worldwide Chairman, MedTech will repre
Price reaction · baseline $182.23 (2022-04-06 close) · hit after-hours · clean, no other JNJ news in the window
day 0 close
-0.3%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , April 7, 2022 Johnson & Johnson (NYSE: JNJ ) will participate in the BofA Securities 2022 Healthcare Conference at the Encore Hotel in Las Vegas, Nevada on Wednesday, May 11 th . Ashley McEvoy, Executive Vice President, Worldwide Chairman, MedTech will represent the Company in a session scheduled at 3:40 p.m. (Eastern Time) .
This conference call will be available to investors and other interested parties by visiting the Johnson & Johnson website at www.investor.jnj.com .
A webcast and podcast replay will be available approximately 48 hours after the live webcast.
Last updated: Apr 7, 2022